Risk of progression of Barrett's esophagus in patients with cirrhosis

被引:3
|
作者
Apfel, Tehilla [1 ]
Lopez, Rocio [1 ]
Sanaka, Madhusudhan R. [1 ]
Thota, Prashanthi N. [1 ]
机构
[1] Cleveland Clin Fdn, Dept Gen Internal Med, Cleveland, OH 44195 USA
关键词
Liver cirrhosis; Barrett's esophagus; Dysplasia; Esophageal neoplasm; Progression; NONALCOHOLIC FATTY LIVER; HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX; METABOLIC SYNDROME; ADENOCARCINOMA; VARICES; METAANALYSIS; ADIPOKINES; DISEASE;
D O I
10.3748/wjg.v23.i18.3287
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To study Barrett's esophagus (BE) in cirrhosis and assess progression to esophageal adenocarcinoma (EAC) compared to non-cirrhotic BE controls. METHODS Cirrhotic patients who were found to have endoscopic evidence of BE confirmed by the presence of intestinal metaplasia on histology from 1/1/2000 to 12/1/2015 at Cleveland Clinic were included. Cirrhotic patients were matched 1: 4 to BE controls without cirrhosis. Age, gender, race, BE length, hiatal hernia size, Child-Pugh (CP) class and histological findings were recorded. Cases and controls without high-grade dysplasia (HGD)/EAC and who had follow-up endoscopies were studied for incidence of dysplasia/EAC and to assess progression rates. Univariable conditional logistic regression was done to assess differences in baseline characteristics between the two groups. RESULTS A total of 57 patients with cirrhosis and BE were matched with 228 controls (BE without cirrhosis). The prevalence of dysplasia in cirrhosis and controls were similar with 8.8% vs 12% with low grade dysplasia (LGD) and 12.3 % vs 19.7% with HGD or EAC (P = 0.1). In the incidence cohort of 44 patients with median follow-up time of 2.7 years [interquartile range 1.0, 4.8], there were 7 cases of LGD, 2 cases of HGD, and 2 cases of EAC. There were no differences in incidence rates of HGD/ EAC in nondysplastic BE between cirrhotic cases and noncirrhotic controls (1.4 vs 1.1 per 100 person-years, P = 0.8). In LGD, cirrhotic patients were found to have higher rates of progression to HGD/EAC compared to control group though this did not reach statistical significance (13.7 vs 8.1 per 100 person-years, P = 0.51). A significant association was found between a higher CP class and neoplastic progression of BE in cirrhotic patients (HR = 7.9, 95% CI: 2.0-30.9, P = 0.003). CONCLUSION Cirrhotics with worsening liver function are at increased risk of progression of BE. More frequent endoscopic surveillance might be warranted in such patients.
引用
收藏
页码:3287 / 3294
页数:8
相关论文
共 50 条
  • [31] Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma
    Bani-Hani, Kamal E.
    Bani-Hani, Bayan K.
    Martin, Iain G.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (43) : 6807 - 6814
  • [32] Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma
    Kamal E Bani-Hani
    Bayan K Bani-Hani
    Iain G Martin
    World Journal of Gastroenterology, 2005, (43) : 6807 - 6814
  • [33] Risk of malignant progression in Barrett's esophagus indefinite for dysplasia
    Ma, M.
    Shroff, S.
    Feldman, M.
    DeMarshall, M.
    Price, C.
    Tierney, A.
    Falk, G. W.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (03)
  • [34] Differences of risk factors and clinical presentations in male and female Taiwanese individuals with Barrett's esophagus
    Lee, Shou-Wu
    Lien, Han-Chung
    Chang, Chi-Sen
    Chang, Chung-Hsin
    Ko, Chung-Wang
    Yeh, Hong-Zen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (10) : 860 - 864
  • [35] Barrett's esophagus: diagnostic challenges and recent developments
    Maru, Dipen M.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (03) : 212 - 221
  • [36] The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
    Kroep, Sonja
    Lansdorp-Vogelaar, Iris
    van der Steen, Alex
    Inadomi, John M.
    van Ballegooijen, Marjolein
    MEDICAL DECISION MAKING, 2015, 35 (06) : 726 - 733
  • [37] Progression from low-grade dysplasia to malignancy in patients with Barrett's esophagus diagnosed by two or more pathologists
    Moole, Harsha
    Patel, Jaymon
    Ahmed, Zohair
    Duvvuri, Abhiram
    Vennelaganti, Sreekar
    Moole, Vishnu
    Dharmapuri, Sowmya
    Boddireddy, Raghuveer
    Yedama, Pratyusha
    Bondalapati, Naveen
    Uppu, Achuta
    Vennelaganti, Prashanth
    Puli, Srinivas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (39) : 8831 - 8843
  • [38] Lifetime Alcohol Consumption and Risk of Barrett's Esophagus
    Thrift, Aaron P.
    Pandeya, Nirmala
    Smith, Kylie J.
    Mallitt, Kylie-ann
    Green, Adele C.
    Webb, Penelope M.
    Whiteman, David C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (07) : 1220 - 1230
  • [39] Radiofrequency ablation for Barrett's esophagus
    Kaimakliotis, Pavlos Z.
    Falk, Gary W.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (04) : 415 - 421
  • [40] Barrett's esophagus
    Ertan, A
    Younes, M
    DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (08) : 1670 - 1673